Brexanolone therapy for moms with postpartum depression
Official title: A Randomized, Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral LPCN 1154A in Women With Postpartum Depression
Run by Lipocine Inc. · NCT07822321 · Data updated 2026-11-12
This trial tests LPCN 1154A against placebo to see if it can help reduce depression symptoms in women with severe postpartum depression.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 15 Years to 45 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Lipocine Inc. Industry-sponsored |
| Locations | 16 sites (Tucson, Arizona and 15 other locations) |
| Status | Recruiting |
| Started | September 2026 |
| Main results expected | August 2027 |
| Study ends | September 2027 |
| Registry record updated | September 16, 2026 |
| Trial ID | NCT07822321 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women up to 45 years old with severe postpartum depression within 18 months after birth and a high HAM-D score, who do not have bipolar, schizophrenia, schizoaffective disorder, active psychosis, recent seizures, or a history of suicidal behavior in the current episode.
✕Probably not a fit
Patients with non-severe depression, alternative etiologies of mood disorder, certain psychiatric histories, active psychosis, recent seizures, or those outside the 18-month postpartum window may not benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a Phase 3 interventional trial evaluating LPCN 1154A as a potential treatment for severe postpartum depression. Participants are adult women up to 45 years old who developed depression around the time of delivery and are within 18 months postpartum, with a high HAM-D score. The study compares LPCN 1154A to placebo to assess efficacy and tolerability, including side effects. Key exclusion criteria include certain psychiatric histories and active psychosis or recent seizure. The trial is sponsored by Lipocine Inc. and conducted at three Lipocine investigational sites in Arizona and California.
Why it matters
Potential benefit: If successful, LPCN 1154A could provide a new treatment option for women with severe postpartum depression and help improve mood and functioning.
How similar studies have gone: Previous trials of similar neuroactive agents in postpartum depression have shown mixed results; this study explores a novel formulation in a Phase 3 setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Key Inclusion Criteria: * Are female between 15 and 45 years of age, inclusive; * Have had a depressive episode that began no earlier than second trimester and no later than the first 4 weeks following delivery * Are \< 18 months postpartum at Screening * Hamilton Depression Rating Scale (HAM-D) 17-item score indicative of severe depression Key Exclusion Criteria: * Have a history of bipolar disorder, schizophrenia or schizoaffective disorder * Are currently experiencing active psychosis per Investigator assessment * Have a history of suicidal behavior associated with the current depressive episode * Have a history of seizure within six months of Screening
Where it's running
-
Lipocine Investigational Site
Tucson, Arizona, United States Recruiting -
Lipocine Investigational Site
Canoga Park, California, United States Recruiting -
Lipocine Investigational Site
Walnut Creek, California, United States Recruiting -
Lipocine Investigational Site
Aurora, Colorado, United States Recruiting -
Lipocine Investigational Site
Decatur, Georgia, United States Recruiting -
Lipocine Investigational Site
Idaho Falls, Idaho, United States Recruiting
Show 10 more locations
-
Lipocine Investigational Site
Chicago, Illinois, United States Recruiting -
Lipocine Investigational Site
New Orleans, Louisiana, United States Recruiting -
Lipocine Investigational Site
Las Vegas, Nevada, United States Recruiting -
Lipocine Investigational Site
Princeton, New Jersey, United States Recruiting -
Lipocine Investigational Site
Manhattan, New York, United States Recruiting -
Lipocine Investigational Site
Chapel Hill, North Carolina, United States Recruiting -
Lipocine Investigational Site
Plano, Texas, United States Recruiting -
Lipocine Investigational Site
Richardson, Texas, United States Recruiting -
Lipocine Investigational Site
Clinton, Utah, United States Recruiting -
Lipocine Investigational Site
Orem, Utah, United States Recruiting
Study contacts
- Study coordinator: Vice President of Clinical Development
- Email: siteinquiry@lipocine.com
- Phone: 801-519-4363
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treating peripartum depression with repetitive transcranial magnetic stimulation
This study tests whether active rTMS can reduce depressive symptoms in pregnant people or those within a year after birth who have peripartum depression.
-
Restoring Emotional Balance With Ketones for Women After Birth
This study tests whether taking a ketone supplement plus group cognitive-behavioral counseling and guided exercise can help women within 12 months after birth who have postpartum depression feel better.
-
Web-based program to help new mothers with postpartum depression
A web-based treatment with therapist support is being tested to see if it helps women 1–12 months after giving birth who have postpartum depression.
-
Methyl-Donor Rich Diet in the Postpartum Period
Researchers will test whether a methyl-donor‑rich diet in the first weeks after birth helps reduce maternal depression and supports breastfeeding and infant growth.
-
Two-Door Doulas: Enhanced vs Standard Medicaid Doula Care in Pregnancy
This trial tests whether an enhanced, earlier, and more frequent doula support program helps pregnant people on Medicaid feel less depression and anxiety after birth compared with the standard Medicaid doula care in Florida.
-
Doula-delivered postpartum support with nurse coordination for people with preterm births in the NICU
This trial tests whether doula-delivered postpartum help, guided by nurses, improves health outcomes and experiences for people with babies under 34 weeks in the NICU, compared to standard postpartum care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.